Cargando…

Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients

This real-world, multicenter, prospective study aims to analyze the cost-effectiveness of prevalent oral antidiabetic drugs, including traditional Chinese medicine and its compounds, used in China. Type 2 diabetes patients initiated on one or several of the most prevalent antidiabetic drugs were rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Gordon, Huang, Zhiyong, Xin, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568544/ https://www.ncbi.nlm.nih.gov/pubmed/34745311 http://dx.doi.org/10.1155/2021/9972386

Ejemplares similares

Real-World Effectiveness and Safety of Lixisenatide as Add-On to Oral Antidiabetic Drugs as Part of Routine Clinical Practice in Bulgaria: LIXODAR Study
por: Temelkova, Nataliya, et al.
Publicado: (2019)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Comparative effectiveness of incident oral antidiabetic drugs on kidney function
por: Hung, Adriana M, et al.
Publicado: (2012)

Antidiabetic therapy in real practice: indicators for adherence and treatment cost
por: Colombo, Giorgio L, et al.
Publicado: (2012)

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014)

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
por: Klatt, Sabine, et al.
Publicado: (2011)

Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
por: Tajima, Atsushi, et al.
Publicado: (2022)

Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study
por: Cheng, Wei, et al.
Publicado: (2021)

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis
por: Gautam, Santosh, et al.
Publicado: (2017)

Correction: Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
Publicado: (2023)

How many oral antidiabetic drugs before insulin?
por: Kelwade, Jayant, et al.
Publicado: (2017)

Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
por: Tzanetakos, Charalampos, et al.
Publicado: (2014)

Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012–2018
por: Engler, Clemens, et al.
Publicado: (2020)

Real World Use of Antidiabetic Drugs in the Years 2011–2017: A Population-Based Study from Southern Italy
por: Ingrasciotta, Ylenia, et al.
Publicado: (2020)

Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs
por: Baser, Onur, et al.
Publicado: (2013)

Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study
por: Kim, Sang Soo, et al.
Publicado: (2015)

Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes
por: Stapff, Manfred Paul
Publicado: (2018)

Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan
por: Yabe, Daisuke, et al.
Publicado: (2020)

Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN)
por: Jude, Edward B., et al.
Publicado: (2019)

Effects of antidiabetic drugs on epicardial fat
por: Xourgia, Eleni, et al.
Publicado: (2018)

Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis
por: Colosimo, Santo, et al.
Publicado: (2021)

The application of transbronchial cryobiopsy in interstitial lung disease: a prospective, multicenter, real-world study
por: Chen, Xiaobo, et al.
Publicado: (2021)

Safety, effectiveness and costs of percutaneous mitral valve repair: A real-world prospective study
por: Willits, Iain, et al.
Publicado: (2021)

Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study
por: Zhang, Yifei, et al.
Publicado: (2020)

Safety of Shujinjianyao pill in clinical real world: A prospective, observational, multicenter, large-sample study Protocol
por: Cui, Xin, et al.
Publicado: (2019)

Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens
por: Morrisette, Taylor, et al.
Publicado: (2022)

Effect of Oral Antidiabetic Drugs on Tuberculosis Risk and Treatment Outcomes: Systematic Review and Meta-Analysis
por: Meregildo-Rodriguez, Edinson Dante, et al.
Publicado: (2022)

Effects of Antidiabetic Drugs on Gut Microbiota Composition
por: Montandon, Sophie A., et al.
Publicado: (2017)

Weight changes following antidiabetic mediation use: Real‐world evidence from health system data
por: Lyu, Beini, et al.
Publicado: (2022)

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
por: Johnson, Ben, et al.
Publicado: (2021)

Nephroprotective Properties of Antidiabetic Drugs
por: Gerdes, Christian, et al.
Publicado: (2023)

Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost–Utility Analysis
por: Men, Peng, et al.
Publicado: (2020)

Early oral feeding following intestinal anastomosis surgery in infants: a multicenter real world study
por: Lu, Changgui, et al.
Publicado: (2023)

Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real‐world data
por: Peng, Ying, et al.
Publicado: (2022)

Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
por: Oh, Kyunghwan, et al.
Publicado: (2023)

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
por: Sun, Bao, et al.
Publicado: (2021)

Adherence to omalizumab: A multicenter "real-world" study
por: Campisi, Raffaele, et al.
Publicado: (2020)

The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone
por: Bailbé, Danielle, et al.
Publicado: (2013)

Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis
por: Lee, Gyeongsil, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_161qb32h44btgf148pbnlipeoc